Overview

Different Reversal Agents in Pediatric Day-case Cancer Surgery

Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to compare the efficacy of sugammadex and neostigmine on reversing neuromuscular blockers in pediatric patients undergoing outpatient surgical procedures.
Phase:
Phase 4
Details
Lead Sponsor:
National Cancer Institute, Egypt
Treatments:
Neostigmine
Neuromuscular Blocking Agents